Light therapy tested for painful mouth sores after stem cell transplant
NCT ID NCT05675930
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This phase 2 trial tests whether photobiomodulation (PBM) — a type of light therapy — can safely treat oral chronic graft-versus-host disease (GVHD), a painful mouth condition that can occur after a stem cell transplant. About 44 participants who have not responded to at least one prior treatment will receive either real PBM or a sham device for 28 days. The main goal is to see if the light therapy can reduce mouth sore severity.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- photobiomodulation (light therapy) using the Thor LX2.3 device
- What this could lead to
- If it works, this could offer a non-drug way to relieve painful mouth sores in people with chronic GVHD, improving their quality of life.
- What could go wrong
- This is a small, early-phase trial (44 people) testing a device, so results may not apply widely. The placebo effect from a sham device could also muddy the findings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GRAFT-VERSUS-HOST DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
RECRUITINGNew York, New York, 10065, United States
-
Memorial Sloan Kettering Cancer Center @ Bergen (Consent only)
RECRUITINGMontvale, New Jersey, 07645, United States
-
Memorial Sloan Kettering Cancer Center @ Commack (Consent only)
RECRUITINGCommack, New York, 11725, United States
-
Memorial Sloan Kettering Cancer Center @ Nassau (Consent only)
RECRUITINGUniondale, New York, 11553, United States
-
Memorial Sloan Kettering Monmouth (Consent only)
RECRUITINGMiddletown, New Jersey, 07748, United States
-
Memorial Sloan Kettering Westchester (Consent only)
RECRUITINGHarrison, New York, 10604, United States
-
Memorial Sloan Kettering at Basking Ridge (Consent only)
RECRUITINGBasking Ridge, New Jersey, 07920, United States
-
National Institute of Health (Data Collection AND Specimen Analysis)
RECRUITINGBethesda, Maryland, 20892, United States
-
University of Pittsburgh Medical Center (Data Collection Only)
RECRUITINGPittsburgh, Pennsylvania, 15213, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a skin biopsy reveal how axatilimab fights scarring in chronic GVHD?
- Can a cancer drug tame graft-versus-host disease when steroids fail?
- New antibody may offer safer shield against transplant complications
- New drug combo aims to tame immune attack after stem cell transplants
- New drug cocktail aims to stop transplant rejection in blood cancer patients
- New eye drops aim to soothe dry eye in bone marrow transplant patients